| http://www.w3.org/ns/prov#value | - This favored Caraco's position, because it is consistent with Congressional intent to get generic drugs to market quickly, particularly for uses not falling within the scope of Orange Book listed patents. (The statutory scheme, in other words, contemplates that one patented use will not foreclose marketing a generic drug for other unpatented ones.)
|
